Biology of Bone Sarcomas and New Therapeutic Developments

Calcif Tissue Int. 2018 Feb;102(2):174-195. doi: 10.1007/s00223-017-0372-2. Epub 2017 Dec 13.

Abstract

Bone sarcomas are tumours belonging to the family of mesenchymal tumours and constitute a highly heterogeneous tumour group. The three main bone sarcomas are osteosarcoma, Ewing sarcoma and chondrosarcoma each subdivided in diverse histological entities. They are clinically characterised by a relatively high morbidity and mortality, especially in children and adolescents. Although these tumours are histologically, molecularly and genetically heterogeneous, they share a common involvement of the local microenvironment in their pathogenesis. This review gives a brief overview of their specificities and summarises the main therapeutic advances in the field of bone sarcoma.

Keywords: Chondrosarcoma; Clinical trials; Ewing sarcoma; Giant cell tumour of bone; Immunotherapy; Osteosarcoma; Tumour microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone Neoplasms / diagnosis
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / etiology*
  • Bone Neoplasms / therapy
  • Female
  • Giant Cell Tumor of Bone / pathology
  • Humans
  • Male
  • Sarcoma / diagnosis
  • Sarcoma / drug therapy
  • Sarcoma / etiology*
  • Sarcoma / therapy
  • Tumor Microenvironment